Who founded Cerespir?

Cerespir was founded by Daniel G. Chain in 2013.

Who are Cerespir's investors?

Cerespir's investors include Vedanta Capital.

How much funding has Cerespir raised?

Cerespir has disclosed $500K raised across 1 round.

Where is Cerespir headquartered?

Cerespir is headquartered in New York, US.

Cerespir

New York, US · Founded 2013 · Delaware corporation · 1 known investors

Find your way into Cerespir

146 people in our graph share verified history with the Cerespir team — schools, employers, funds. One of them is your warm intro.

Jung Lee, PhDunlockedknows Adrian N. Hobden · together at GlaxoWellcome (overlapped)

×3knows the team · via GlaxoWellcome

×2knows the team · via University of Cambridge

×6knows the team · via University of Leicester

Pharmaceutical company developing novel approach to Alzheimer's disease

Biotech

Founders & leadership

Cerespir was founded in 2013 by Daniel G. Chain.

Daniel G. ChainFounder

Adrian N. Hobden inExecutiveAdrian N. Hobden established and led the Department of Genetics and Molecular Biology at Glaxo PLC, managing biotech partnerships and business development across the pharmaceutical industry. He founded Myriad Pharmaceuticals and scaled it to 220 employees, overseeing clinical development programs and a major placebo-controlled trial for an experimental Alzheimer's treatment.

Board

Samuel JesselsonBoard director

Michael JesselsonBoard director

Investors · 1

Vedanta CapitalNew York

Reported raises · per SEC filings

Form D private placements

$500K disclosed across 1 round · 2016

▶$500KraisedSep 2016 · 2 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Adrian N. HobdenExecutive Officer, Director
Daniel G. ChainExecutive Officer, Director
Samuel JesselsonDirector
Michael JesselsonDirector

Offering amount: $500K
Amount sold: $500K
Proceeds to insiders: $135K
First sale: Aug 2016
Incorporated: Corporation, Delaware, 2013
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Cerespir do?: Pharmaceutical company developing novel approach to Alzheimer's disease
Who founded Cerespir?: Cerespir was founded by Daniel G. Chain in 2013.
Who are Cerespir's investors?: Cerespir's investors include Vedanta Capital.
How much funding has Cerespir raised?: Cerespir has disclosed $500K raised across 1 round.
Where is Cerespir headquartered?: Cerespir is headquartered in New York, US.